Despite the use of some experimental Ebola treatments, "on a realistic level" the focus is containment, according to a leading microbiologist.
Professor Mark Fielder, Honorary General Secretary of the Society for Applied Microbiology, told Good Morning Britain: "It's a two pronged attack, the world is looking at treatments, the world is looking at therapies but what we are looking at on a realistic level is we're looking at infection control."
It was confirmed on Monday that an experimental drug, not yet tested for safety or effectiveness on humans, will be given to two Liberian doctors infected with the disease.
A clinical trial of an experimental vaccine against the deadly virus is set to start shortly, according to British drugmaker GlaxoSmithKline, which is co-developing the product with American scientists.
UK trials of a vaccine for the Ebola virus began today - but some experts complain that the response has been a long time coming.
A Swansea doctor who took leave to treat Ebola patients in Africa, is back on the wards after three weeks in isolation.
The first British case of Ebola in the outbreak in West Africa has been confirmed. So how would repatriation work are what are the risks?